Table 4.
Anti-Jo-1 | Anti-PL-7 | Anti-PL-12 | Anti-EJ | Anti-OJ | |
n = 36 | n = 22 | n = 9 | n = 12 | n = 5 | |
Ground-glass opacity | 35 (97.22%) | 22 (100% | 9 (100%) | 11 (91.67%) | 5 (100%) |
Reticular opacities | 24 (66.67%) | 20 (90.91%) | 7 (77.78%) | 8 (66.67%) | 3 (60.00%) |
Subpleural line | 11 (30.55%) | 6 (27.27%) | 3 (33.33%) | 1 (8.33%) | 1 (20.00%) |
Honeycombing opacity | 1 (2.78%) | 5 (22.73%) | 1 (11.11%) | 2 (16.67%) | 3 (60.00%) |
Consolidation | 17 (47.22%) | 10 (45.45%) | 4 (44.44%) | 4 (33.33%) | 1 (20.00%) |
Nodular | 4 (11.11%) | 1 (4.55%) | 0 (0%) | 0 (0%) | 0 (0%) |
Traction bronchiectasis | 9 (25.00%) | 4 (18.18%) | 1 (11.11%) | 2 (16.67%) | 2 (40.00%) |
Pericardial effusion | 4 (11.11%) | 3 (13.64%) | 1 (11.11%) | 2 (16.67%) | 1 (20.00%) |
Air bronchogram | 11 (30.55%) | 5 (22.73%) | 3 (33.33%) | 5 (41.67%) | 1 (20.00%) |
Pleural effusion | 2 (5.56%) | 2 (9.09%) | 1 (11.11%) | 1 (8.33%) | 3 (60.00%) |
HRCT = high-resolution computed tomography.